Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU
SWAT
1 other identifier
interventional
160
1 country
1
Brief Summary
There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJune 4, 2025
May 1, 2025
2 years
April 19, 2024
May 29, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Recruitment percentage
Family member participants enrolled/ family member participants approached
At enrolment
Retention percentage
Family member participant completing follow-up/family member participants enrolled
From enrolment until 6 month follow-up completion
Study Arms (4)
Both recruitment strategies
EXPERIMENTALConsent form with Infographic + Large compensation
Neither recruitment strategy
NO INTERVENTIONConsent form + No compensation
One recruitment strategy - Infographic
EXPERIMENTALConsent form with Infographic + No compensation
One recruitment strategy - Compensation
EXPERIMENTALConsent form + Large compensation
Interventions
Potential participants are provided a visual infographic depicting the key elements of the written consent form in addition to the standard written consent form.
Potential participants are provided an e-gift card to Amazon or Second Cup as a reward for completing the enrollment questionnaire.
Eligibility Criteria
You may qualify if:
- Has family member admitted to an intensive care unit.
- Expected hospital stay \> 48 hours
- Able to participate in English or French
You may not qualify if:
- Has another family member participating in the trial
- Repeat admissions within the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jewish General Hospital
Montreal, Quebec, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael J Goldfarb, MD, MSc
Lady Davis Institute, McGill University, Jewish General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Staff, Division of Cardiology
Study Record Dates
First Submitted
April 19, 2024
First Posted
September 19, 2024
Study Start
May 1, 2024
Primary Completion
April 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share